baber/WOPTO huggingface dataset:
Patent CA-2706003-A1 (CA)
Inventor: VON TROTHA THILO
IPC: C10G65/04
Filed: 2008-11-18
Abstract: The invention relates to a process and a device for the hydrodesulphurisation of an olefin and hydrogen-containing feed gas. The feed gas can be mixed with further hydrogen and subdivided into at least two feed streams. The first feed gas stream is introduced separately into the reactor and is passed through a first catalyst bed which contains the catalyst pellets deposited on a suitable support or grid.  The feed gas is heated in the hydrogenation reaction. Downstream of first catalyst bed, further feed gas is supplied which serves to cool the feed gas permitting that the gas can then be passed through a second catalyst bed. Downstream of the second catalyst bed there may be further catalyst beds and further feed gas supply devices. The catalyst beds can be provided in the reactor in any number, type and shape. These process conditions ensure that a product gas be obtained which essentially contains no other sulphur compound than hydrogen sulphide.
Patent CA-2709221-A1 (CA)
Inventor: CAVENDER TRAVIS W
IPC: E21B43/119
Filed: 2008-12-18
Abstract: Casing deformation and control for inclusion propagation in earth formations. A method of forming at least one inclusion in a subterranean formation includes the steps of : installing a liner within a casing section in a wellbore intersecting the formation; and expanding the liner and the casing section, thereby applying an increased compressive stress to the formation.  Another method of forming the inclusion includes the steps of : installing an expansion control device on a casing section, the device including at least one latch member;  expanding the casing section radially outward in a wellbore, the expanding step including widening at least one opening in a sidewall of the casing section, and displacing the latch member in one direction; and preventing a narrowing of the opening after the expanding step, the latch member resisting displacement thereof in an opposite direction.
Patent CA-2709357-A1 (CA)
Title: Mesalazine tablet
Inventor: UGWOKE MICHAEL I
IPC: A61K9/36
Filed: 2008-12-19
Abstract: Disclosed are mesalazine tablets and a method for their preparation. The mesalazine tablets comprise a tablet core, a first coating layer, and a second coating layer. The tablet core comprises mesalazine; the first coating layer comprises a cellulose derivative and/or povidone, and the second coating layer comprises methacrylic acid/methyl methacrylate copolymer and an antitack agent. The tablets show a high degree of uniformity and reproducibility and release mesalazine starting at pH 6.8 and are used in the treatment of colorectal diseases.
Patent CA-2711051-A1 (CA)
Inventor: CAZE PHILIPPE
IPC: B01J19/24
Filed: 2008-12-30
Abstract: Disclosed is a reactor for reacting fluids such as fluids in continuous flow, the reactor including a multicellular extruded body having cells extending in parallel in a direction from a first end of the body to a second end, the body having a first plurality of cells open at both ends of the body and a second plurality of said cells closed at one or both ends of the body, the second plurality being contiguous cells and cooperating to define at least in part a fluidic passage extending at least partly through the body.  The fluidic passage desirably has a serpentine path back and forth along cells of the second plurality of cells, and the passage connects laterally from cell to cell, within cells of the second plurality, at or near the ends of the body.
Patent CA-2712189-A1 (CA)
Title: Installation de production d'eau chaude sanitaire pour une habitation collective
Inventor: LABAUME DAMIEN
IPC: F24F12/00
Filed: 2009-01-19
Abstract: L'installation de production d'eau chaude sanitaire pour une habitation collective (1 ) comportant une pluralité de chauffe-eau, destinés à équiper une pluralité de logements individuels (2) de l'habitation (1 ). Chaque chauffe-eau comporte un réservoir (3) à l'intérieur duquel est stocké un fluide à chauffer, chaque logement (2) étant en outre équipé d'au moins une conduite d'extraction d'air (4), en particulier au niveau des pièces techniques (5), raccordée à un réseau d'extraction d'air (8) commun aux différents logements (2). Chaque logement comportant en outre des moyens d'échange de chaleur (10) agencés pour échanger de la chaleur entre l'air extrait circulant dans la conduite d'extraction d'air (4) et le fluide contenu dans le réservoir (3), de manière à chauffer le fluide en vue de produire de l'eau chaude sanitaire.
Patent CA-2713586-A1 (CA)
Inventor: ISHII TAKESHI
IPC: G02B5/122
Filed: 2010-08-19
Abstract: A reflector for a vehicle can include a plurality of retroreflective elements configured to retroreflect incident light incident parallel to a horizontally-arranged reference axis, obliquely upward at a prescribed angle with respect to the reference axis. The plurality of retroreflective elements can each include: a first reflection surface inclined at an angle ANG1 to the reference axis; a second reflection surface inclined at an angle ANG2 to the reference axis, and formed in a position reached after the second reflection surface is rotated from the first reflection surface through an angle ROT1 around the reference axis as a center; and a third reflection surface inclined at an angle ANG3 to the reference axis and formed in a position reached after the third reflection surface is rotated from the first reflection surface through an angle ROT2 around the reference axis as a center in a direction opposite to the second reflection surface, the first to third reflection surfaces arranged so as to form corners of a substantial cube, wherein a condition of following expressions is satisfied: ANG2 > ANG3; ANG2 > ANG1; and ROT1 > ROT2 > 120 degrees.
Patent CA-2716094-A1 (CA)
Inventor: GEIST WYATT DRAKE
IPC: A61B17/88
Filed: 2008-02-21
Abstract: The present invention describes a magnetic targeting system suitable for guiding a biocompatible device to a target area within the body (in vivo) and method of using the same. The system includes a targeting member having a steering material and is attached to the biocompatible device. The system also includes at least one anchoring member constructed and arranged for the inclusion of a magnetic material effective for influencing the traversal of the steering material, in vivo. The magnetically influenced anchoring member interacts with the targeting member such that the biocompatible device is positionable relative to the target area.
Patent CA-2716810-A1 (CA)
Inventor: WALMSLEY SIMON R
IPC: B41J2/12
Filed: 2004-05-27
Abstract: A method of at least partially compensating for errors in ink dot placement by at least one of a plurality of nozzles due to erroneous rotational displacement of a printhead module relative to a carrier, the nozzles being disposed on the printhead module, the method comprising the steps of: (a) determining the rotational displacement; (b) determining at least one correction factor that at least partially compensates for the ink dot displacement; and (c) using the correction factor to alter the output of the ink dots to at least partially compensate for the rotational displacement.
Patent CA-2717116-A1 (CA)
Inventor: OKONIEWSKI GREGORY G
IPC: A61B17/02
Filed: 2010-10-06
Abstract: A retraction assembly is provided for retracting body tissue away from an operative site.  The retraction device generally includes a first jaw and a second jaw connected by a biasing member. The biasing member urges distal ends of the first and second jaws together to grasp the body tissue. An anchoring assembly is connected to the retraction device for reposition the grasped target body tissue away from the operative site. The anchoring assembly includes a surgical needle and a length of suture material attached to the retraction device. There is also provided an applicator instrument having a hollow outer tube for receipt of the retraction device and to position and advance the retraction device over the body tissue. A  pusher is provided and is movable within the hollow outer tube, and engageable with the retraction device, to force the retraction device out of the hollow outer tube and about the body tissue.
Patent CA-2717427-A1 (CA)
Inventor: MAECKE HELMUT
IPC: C07K7/08
Filed: 2009-02-27
Abstract: To provide a diagnostic and therapeutic medicament, a bombesin analog peptide antagonist conjugate is provided which has general Formula (I): [A-(B) n ] x -C, wherein A is a metal chelator comprising at least one radionuclide metal, B is a spacer linked to N-tenninal of C or a covalent bond and C is a bombesin analog peptide antagonist having a sequence as claimed, where further x is an integer from 1 to 3 and n is an integer from 1 to 6.
Patent CA-2717517-A1 (CA)
Inventor: GRGAC STEVE
IPC: B65D19/38
Filed: 2010-10-13
Abstract: A shipping pallet having a top deck, a bottom skid, and a plurality of posts disposed between and separating the top deck and the bottom skid such that at least one tow fork is able to be positioned between the top deck and the bottom skid. The shipping pallet also includes a plurality of collars formed as part of the top deck, and the posts are integrally formed as part of the bottom skid. Each of the plurality of posts is received into and connected to a respective one of the plurality of collars.                      There is also a plurality of reinforcements, and each of the reinforcements is disposed within and surrounded by a post. Each post and reinforcement is received into one of the collars, and the post is connected to the collar through a connection point, such as an adhesive joint or thermoplastic weld.
Patent CA-2718294-A1 (CA)
Inventor: TU HOSHENG
IPC: A61F2/14
Filed: 2002-04-08
Abstract: The invention relates generally to medical devices and methods for reducing the intraocular pressure in an animal eye and, more particularly, to stent type devices for permitting aqueous outflow from the eye's anterior chamber and associated methods thereof for the treatment of glaucoma. Some aspects provide a self-trephining glaucoma stent and methods thereof which advantageously allow for a 'one-step' procedure in which the incision and placement of the stent are accomplished by a single device and operation. This desirably allows for a faster, safer, and less expensive surgical procedure.
Patent CA-2718742-A1 (CA)
Title: Device for conveying products
Inventor: KRUTMANN ROGER
IPC: B65C1/02
Filed: 2009-02-04
Abstract: The invention relates to a device for conveying products (2), particularly food products, consisting of a horizontal conveying path supported by a base and having a drive means (1) substantially extending in the horizontal direction, wherein the drive means (1) is reversibly driven, and is associated with at least one auxiliary conveyor device (3, 4) also supported by the base, said device having a conveying means (5) for the product (1) driven by the drive means, and having supporting means (3, 4) by means of which the product (1) is laterally supported and carried at a distance from the drive means (1).
Patent CA-2719433-A1 (CA)
Inventor: HIRUKAWA MASAYUKI
IPC: B60R99/00
Filed: 2010-10-26
Abstract: A structure for mounting ancillaries on a vehicle is designed to suppress vibrations. One end of a first bracket in plate form extends downwardly and is fixed to the body frame and an opposite end of the first bracket preferably supports a reservoir. Additionally, the first bracket supports a further ancillary adjacent the reservoir. The reservoir is attached to a forward end of the first bracket functions and acts as a deadweight that suppresses vibrations of the forward end of the first bracket The structure also suppresses and attenuates vibration of the regulator attached to the first bracket.
Patent CA-2719569-A1 (CA)
Inventor: CAROFF EVA
IPC: A61P7/02
Filed: 2009-04-09
Abstract: The present invention relates to 2-phenyl-4-cyclopropyl-pyrimidine derivatives of formula I  and their use as P2Y12 receptor antagonists in the treatment and/or prevention or peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals. ( see formula Formula I)
Patent CA-2722711-A1 (CA)
Inventor: SWEARINGEN EKATERINA N
IPC: C07C21/18
Filed: 2008-05-23
Abstract: Disclosed is a method for the synthesis of fluorinated alkenes comprising contacting a fluorinated alkyne of the formula R1 C.ident.C R2, wherein R1 and R2 are independently selected from CF3, C2F5, C3F7, and C4F9, in a pressure vessel, with a Lindlar catalyst, with substantially one molar equivalent of hydrogen, to make the corresponding cis-alkene of formula R1 C.ident.C R2 with high selectivity, wherein said hydrogen is added in portions over a period of time, so as to produce an initial pressure in the pressure in the vessel of no more than about 100 psi.
Patent CA-2723086-A1 (CA)
Inventor: HRUBY DENNIS E
IPC: A61K31/4184
Filed: 2009-04-29
Abstract: Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, Pichinde, and LCMV), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever and Crimean-Congo hemorrhagic fever).
Patent CA-2724459-A1 (CA)
Inventor: DEKKER PETRUS JACOBUS THEODORUS
IPC: C12N15/57
Filed: 2009-05-28
Abstract: A polypeptide having proline-specific protease activity which comprises the amino acid sequence set out in SEQ  ID NO: 3 or an amino acid sequence encoded by the nucleotide sequence of SEQ  ID NO: 1 and/or SEQ ID NO: 2, or a variant thereof or a fragment of either thereof. The invention also relates to methods for using the polypeptide in industrial processes.  Also included in the invention are cells transformed with a polynucleotide according to the invention suitable for producing these proteins.
Patent CA-2728156-A1 (CA)
Title: Pyridone compounds
Inventor: KAMIKUBO TAKASHI
IPC: A61K31/538
Filed: 2009-06-16
Abstract: [Problems] A useful compound which can be used as a pharmaceutical, in particular, an agent for treating peripheral arterial occlusive disease is provided. [Means for Solution] The present inventors have conducted extensive studies on EP4 receptor agonists, and as a result, have found that a novel pyridone compound, in which a group having an acidic group is substituted at the 1-position of the pyridone ring, the 6-position is bonded with an aromatic ring group via a linking part, and the linking part contains a nitrogen atom, has an excellent EP4 receptor agonistic action, thereby completing the present invention. Since the compound of the present invention has an excellent EP4 receptor agonistic action, it is useful as a pharmaceutical, in particular, as an agent for treating peripheral arterial occlusive disease.
Patent CA-2728202-A1 (CA)
Inventor: MARTINEZ SARAH
IPC: A23K1/16
Filed: 2008-06-16
Abstract: The invention relates to an effervescent composition for adding to the drinking water of an animal.  The composition comprises an effervescent agent and a palatant. The composition may be used in hydration treatment of an animal, as an additive for animal drinking water and for delivering a micronutrient or functional ingredient.  Animals are encouraged to drink more drinking water by the effervescent composition.
Patent CA-2728330-A1 (CA)
Title: Multifaceted segmented waveguide structure for planar waveguide devices
Inventor: BIDNYK SERGE
IPC: G02B6/12
Filed: 2009-06-17
Abstract: Segmented waveguide structures provide mode matching in planar lightwave circuits between waveguides and other waveguiding structures, e.g. slab waveguides and optical fibers. The present invention eliminates back reflections from the core segments by etching the leading and trailing faces of the core segments with a plurality of parallel facet sections, which are rearwardly offset in the transmission direction by an odd number of quarter wavelengths.
Patent CA-2728669-A1 (CA)
Inventor: GREGORY CHRISTOPHER
IPC: A61K38/40
Filed: 2009-06-18
Abstract: The invention relates to methods for modulating granulocyte activation and migration, use of such methods in the treatment of diseases and compositions which may be employed in such methods and uses. In particular, the modulation of granulocyte activation/migration is achieved by increasing or decreasing the amount of lactoferrin in the vicinity of said granulocytes.
Patent CA-2729851-A1 (CA)
Inventor: HAYS PUTNAM ANNA-MARIA A
IPC: C07K19/00
Filed: 2009-07-22
Abstract: Modified bovine G-CSF polypeptides and uses thereof are provided.
Patent CA-2730279-A1 (CA)
Inventor: MACLACHLAN GILBERT J
IPC: B01D35/00
Filed: 2009-07-10
Abstract: A water screen or conveyor belt module includes one or more projections in its top surface for increasing the surface area of the top surface. Each projection includes fluid flow openings that provide a pathway for liquid to drain or fluid to flow between the top and bottom of the module. The fluid flow openings may comprise slots extending in the lengthwise direction of the module and extending into the module.
Patent CA-2731712-A1 (CA)
Title: Automatic gain control (agc) method for an ion trap and a temporally non-uniform ion beam
Inventor: SCHWARTZ JAE C
IPC: H01J49/00
Filed: 2009-07-22
Abstract: An automatic gain control (AGC) technique and apparatus is introduced herein for any temporally non-uniform ion beam, such as, for example, an ion beam produced by a MALDI ion source so as to minimize space charge effects. The disclosed configurations and techniques can be achieved by using an ion optical gating element and applying a desired signal waveform (e.g., a square wave) having a predetermined duty cycle. The applied voltage amplitude of such a signal can be configured to switch between a voltage which fully transmits the ions, and a voltage which does not transmit any ions. The frequency is chosen to result in a period which is significantly lower than the smallest non-uniformity period. Techniques of the present invention can also be extended to methods of AGC which can use a single ion injection event from the ion source to avoid variations in ion numbers from an unstable ion source.
Patent CA-2733039-A1 (CA)
Inventor: MEULEMAN ERIK EVERHARDUS BERNARDUS
IPC: B01D61/36
Filed: 2009-08-19
Abstract: The invention is a process and apparatus for separating liquid mixtures. The process of the invention comprises passing the liquid mixture over a permeable non-porous selective membrane, whereby at least part of the liquid stream passes through said membrane leaving the other side as a vapor, with the remainder of the liquid stream forming a retentate stream.  The vapor is condensed on a condenser surface to give a distillate stream, said condenser surface forming a non-permeable heat conducting separation wall between said distillate stream and a cooling stream which is the feed or retentate stream. The distance between said membrane and said condenser surface is smaller than 10 mm. The vapor pressure of said distillate stream is lower than that of the compounds in the liquid stream for which the membrane is selective, resulting in sufficient driving force for the separation to occur.
Patent CA-2735197-A1 (CA)
Inventor: RAJ ARJUN
IPC: C07H21/00
Filed: 2009-09-10
Abstract: A method for probing a target sequence of messenger ribonucleic acid molecules (mRNA's) in a fixed, permeabilized cell, said target sequence including at least 30 non- overlapping probe binding regions of 15-100 nucleotides, comprising immersing said cell in an excess of at least 30 nucleic acid hybridization probes, each singly labeled with the same fluorescent label and each containing a nucleic acid sequence that is complementary to a different probe binding region of said target sequence; washing said fixed cell to remove unbound probes; and detecting fluorescence from said probes.
Patent CA-2736564-A1 (CA)
Inventor: LI CHIANG JIA
IPC: A01N31/14
Filed: 2008-09-10
Abstract: The present invention relates to the composition and methods of use of Stat3 pathway inhibitors or cancer stem cell inhibitors in combination treatment of cancer.
Patent CA-2737851-A1 (CA)
Title: Controlled release preparation
Inventor: AKIYAMA YOHKO
IPC: A61K9/16
Filed: 2003-10-15
Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.
Patent CA-2738001-A1 (CA)
Inventor: GOEPFERT ULRICH
IPC: C07K16/00
Filed: 2009-10-21
Abstract: It is reported herein a method for the determination of the amount of immunoglobulin-encoding mRNA  compris-ing: a) providing a sample, b) performing a polymerase chain reaction for amplifying the light chain with the primers of SEQ ID  NO: 23 and 24 and the probe of SEQ ID NO: 33, and/or c) performing a polymerase chain reaction for amplifying the heavy chain with the primers of SEQ ID NO: 19 and 21 and the probe of SEQ ID NO: 40, and d) quantitating with an efficiency of 2Ø The primers with SEQ ID NOs 23 and 24 bind at positions CL 247-266 and CL166-185, respectively, and the probe with SEQ ID NO:  33 binds at 189-212 in human IgG koppa chain. The primer with SEQ ID NO: 19 binds at CH region 2 position 220-237 and the primer with SEQ ID NO: 21 binds at CH region 3 position 114-133. Finally the probe with SEQ ID NO: 40 binds from position 315 in CH2 to position 7 in CH3.
Patent CA-2739157-A1 (CA)
Inventor: GILLIS RUSSEL VINCENT
IPC: F02B67/06
Filed: 2011-05-05
Abstract: A tensioning device is provided to aid in the maintenance and replacement of a drive member of a drive system. The tensioning device operates to maintain tension in the drive member during prolonged use of the drive system through a biased roller that receives and guides the drive member and adapts continuously to maintain tension as the drive member changes properties through use. The tensioning device further operates to ease the replacement of the drive member by being rotatable against the bias to provide slack within the drive member, such that the drive member may be removed from the belt drive system. The tensioning device includes an arm and a base, with the arm being capable of limited rotation about the base. The arm includes the roller for guiding the drive member and is biased in one direction to maintain tension within the drive member. The arm may be rotated against the bias towards an engaged position wherein the arm is restricted from counter rotation in the direction of the bias. While in (or substantially in) the engaged position, slack is introduced within the drive member such that the drive member may be removed. When a new or refurbished drive member has been replaced to the drive system, a further rotation of the arm disengages the arm from its restriction and is biased back towards a position of tension wherein the roller re-engages with the drive member to ensure tension in the belt drive system.